Susan E. Barrowcliffe, General Manager, Europe at Aimmune Therapeutics, Inc. (AIMT), sold 6,110 shares at $22.00 ($134K) on 2017-07-21, disclosed to the SEC on 2017-07-25.
Open-market sale of $134k AIMT by General Manager, Europe. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.00 | 960 | $21K | 15.7% |
| 2 | $22.00 | 500 | $11K | 8.2% |
| 3 | $22.00 | 4,650 | $102K | 76.1% |
| Total | $22.00 avg | 6,110 | $134K | 100% |
| Filing → |
| AIMT | SELL | 2017-09-27 | $500K | — | Filing → |
| AIMT | SELL | 2017-09-07 | $405K | — | Filing → |
| AIMT | SELL | 2017-07-31 | $11K | — | Filing → |